Bausch health companies inc. (BHC)
CashFlow / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08
Cash Flows From Operating Activities
Cash Flows From Operating Activities
Net loss

-1,783

-4,144

2,404

-2,408

-288

880

-863

-116

159

-208

176

199

Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization of intangible assets

2,075

2,819

2,858

2,866

2,467

1,614

2,015

986

612

254

149

102

Amortization and write-off of debt premiums, discounts and issuance costs

63

79

151

118

145

70

89

36

27

21

21

18

Asset Impairment Charges

75

568

714

422

304

145

-

-

-

-

-

69

Goodwill, Impairment Loss

0

2,322

312

1,077

0

0

-

-

-

-

-

-

Amortization of discounts on long-term debt

-

-

-

-

-

-

-

-

-

-

5

-

Amortization of deferred financing costs

-

-

-

-

-

-

-

-

-

-

3

0

In-process research and development impairments

-

-

-

-

-

-

151

167

109

89

59

-

Acquisition accounting adjustment on inventory sold

-

-

-

38

134

27

372

78

59

53

-

-

Acquisition-related contingent consideration

12

-9

-289

-13

-23

-14

-29

-5

-10

-

-

-

Allowances for losses on trade receivable and inventories

75

69

119

174

115

81

68

21

5

6

8

4

Deferred income taxes

-230

-144

-4,386

-236

-160

4

-515

-319

-222

-55

-16

-90

(Gain) loss on disposal of assets and businesses

31

-6

579

8

-5

254

-10

-10

5

-

-24

-

Gain (Loss) Related to Litigation Settlement

-1,401

27

-226

-59

-37

45

-220

-56

-11

-52

-6

-

Insurance proceeds for legal settlement

0

0

60

0

0

-

-

-

-

-

-

-

Payments of accrued legal settlements

15

224

221

69

33

3

180

41

26

44

30

93

Loss on deconsolidation

-

-

-

-

-

0

-

-

-

-

-

-

Share-based compensation

102

87

87

165

140

78

45

66

94

98

5

7

Tax expense (benefit) from share-based compensation

-

-

-

-

-

-

24

-12

-26

-

-

-

Foreign exchange loss

-7

19

106

-14

-95

-135

-9

23

4

1

-

-

Interest expense on cross-currency swaps

9

0

0

-

-

-

-

-

-

-

-

-

Gain on sale of marketable securities

-

-

-

-

-

-

-

-

22

-11

-

-

Additions to accrued legal settlements

-

-

-

-

-

-

-

-

-

-

-

32

Gain (Loss) on Extinguishment of Debt

-42

-119

-122

0

-20

-130

-65

-20

-36

-

-

-

Payments of contingent consideration adjustments, including accretion

1

2

4

28

-

-11

11

2

0

-

-

-

Gain on disposal of investments

-

-

-

-

-

-

-

-

-

-

-

6

Other

-36

17

22

-26

33

-32

3

13

18

-7

0

0

Changes in operating assets and liabilities:
Accrued contract costs

-

-

-

-

-

-

-

-

-

-

-

45

Trade receivables

-39

-216

-417

34

626

572

300

175

164

-25

26

-26

Inventories

209

5

-7

164

276

193

122

80

11

-7

33

-16

Prepaid expenses and other current assets

-1

72

-33

-232

91

110

-121

-11

3

-7

0

-0

Accounts payable, accrued and other liabilities

-149

-121

387

-144

325

318

-76

-8

42

-52

-

-

Accounts payable

-

-

-

-

-

-

-

-

-

-

30

-6

Accrued liabilities

-

-

-

-

-

-

-

-

-

-

32

4

Income taxes payable, net

-

-

-

-

-

-

-

-

-

-9

0

8

Deferred revenue

-

-

-

-

-

-

-

-

-

-

-13

-11

Net cash provided by operating activities

1,501

1,501

2,290

2,087

2,257

2,312

1,042

656

640

263

360

204

Cash Flows From Investing Activities
Acquisition of businesses, net of cash acquired

180

-5

0

19

15,458

1,102

5,253

3,485

2,464

-308

-

101

Acquisition of intangible assets and other assets

8

78

165

56

68

179

69

73

327

84

761

-

Purchases of property, plant and equipment

270

157

171

235

235

292

115

107

58

16

7

21

Settlement of foreign currency forward exchange contracts

-

-

-

-

-

0

0

-

-

-

-

-

Purchases of marketable securities

16

7

7

1

49

72

18

7

-

-

-

-

Proceeds from sale of marketable securities

-

-

-

-

67

53

35

624

86

7

1

4

Purchase of equity method investment

-

-

-

-

-

76

0

0

81

-

3

-

Proceeds from sale of equity method investment

-

-

-

-

-

76

0

0

-

-

-

-

Proceeds from sale of marketable securities

10

7

2

17

-

-

-

-

-

-

-

-

Proceeds from sale of assets and businesses, net of costs to sell

45

34

3,253

199

13

1,492

41

92

36

15

28

-

Reduction of cash due to deconsolidation

-

-

-

30

0

0

-

-

-

-

-

-

Net settlement of assumed derivative contracts

-

-

-

-

184

0

0

-

-

-

-

-

Other

-

-

-

-

31

0

0

8

0

-

-

-

Additions to marketable securities

-

-

-

-

-

-

-

-

-

-

-

6

Proceeds on disposal of investments, net of costs

-

-

-

-

-

-

-

-

-

-

-

-25

Other

0

0

25

0

-

-

-

-

-

1

-0

7

Net cash used in investing activities

-419

-196

2,887

-125

-15,577

-100

-5,380

-2,965

-2,808

228

-742

-107

Cash Flows From Financing Activities
Cash Flows From Financing Activities
Issuance of long-term debt, net of discounts

5,960

8,944

9,424

1,220

17,817

1,630

8,385

6,005

5,388

992

350

-

Repayments of Long-term Debt

4,406

10,101

14,203

2,436

2,055

3,888

6,326

1,929

2,004

537

-

-

Borrowings of short-term debt

12

0

1

3

8

19

27

35

0

-

-

-

Repayments of short-term debt

12

3

8

3

8

28

75

31

0

-

-

-

Repayments of convertible notes assumed

-

-

-

-

-3,123

0

0

-

613

254

-

-

Cash dividends paid

-

-

-

-

-

-

-

-

-

356

147

180

Issuance of common stock, net

-

-

-

-

1,433

0

2,307

0

0

-

-

-

Repurchases of common shares

-

-

-

-

72

0

55

280

639

60

-

29

Proceeds from exercise of stock options

-

-

-

33

30

17

10

23

41

58

0

-

Tax (expense) benefit from share-based compensation

-

-

-

-

-

-

24

12

26

-

-

-

Cash settlement of convertible debt

-

-

-

-

-

-

-

606

0

-

-

-

Cash settlement of call options

-

-

-

-

-

-

-

-

66

37

-

-

Acquisition of noncontrolling interest

-

-

-

-

-

-

-

-

-52

-

-

-

Payments of employee withholding taxes related to share-based awards

40

10

4

11

88

44

65

31

59

14

-

-

Payments of acquisition-related contingent consideration

35

37

45

-

-

-

-

-

-

-

-

-

Payments of deferred consideration

0

18

0

-

-

-

-

-

-

-

-

-

Payments of acquisition-related contingent consideration

-

-

-

123

151

106

130

103

31

-

-

-

Payments of deferred consideration

0

18

0

540

55

0

0

-

-

-

-

-

Payments of financing costs

28

102

110

97

103

52

72

33

40

4

26

-

Other

-

-

-

-

9

8

2

4

0

-

-

-

Advances under credit facilities

-

-

-

-

-

-

-

-

-

-

130

-

Repayments under credit facilities

-

-

-

-

-

-

-

-

-

-

130

-

Other

-8

-26

-18

-9

-

-

-

-

-

0

-0

-0

Net cash used in financing activities

1,443

-1,353

-4,963

-1,963

13,624

-2,460

4,027

3,057

1,948

-213

177

-210

Effect of exchange rate changes on cash and cash equivalents

-4

-26

41

-54

-30

-29

-5

3

-10

0

1

-2

Net (decrease) increase in cash and cash equivalents and restricted cash

2,521

-74

255

-55

274

-

-

-

-

-

-

-116

Net (decrease) increase in cash and cash equivalents

-

-

-

-

-

-277

-315

752

-230

279

-203

-

Non-Cash Investing and Financing Activities
Acquisition of Valeant, debt assumed

-

-

-

-

-

-

-

-

-

2,913

-

-

Acquisition of businesses, contingent and deferred consideration obligations at fair value (Restated)

-

-

-

-

-

-

76

145

443

-

-

-

Settlement of convertible debt, equity issued

-

-

-

-

-

-

-

-

892

-

-

-

Acquisition of businesses, debt assumed

-

-

-

-

-

-

4,264

825

0

-

-

-

Long-term debt related to acquisition of business

-

-

-

-

-

-

-

-

-

-

26

-